269 related articles for article (PubMed ID: 25749047)
1. Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.
Burks J; Reed RE; Desai SD
Oncotarget; 2015 Mar; 6(9):7221-31. PubMed ID: 25749047
[TBL] [Abstract][Full Text] [Related]
2. ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
Burks J; Reed RE; Desai SD
Oncogene; 2014 Feb; 33(6):794-803. PubMed ID: 23318454
[TBL] [Abstract][Full Text] [Related]
3. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.
Desai SD; Reed RE; Burks J; Wood LM; Pullikuth AK; Haas AL; Liu LF; Breslin JW; Meiners S; Sankar S
Exp Biol Med (Maywood); 2012 Jan; 237(1):38-49. PubMed ID: 22185919
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway.
Desai SD; Haas AL; Wood LM; Tsai YC; Pestka S; Rubin EH; Saleem A; Nur-E-Kamal A; Liu LF
Cancer Res; 2006 Jan; 66(2):921-8. PubMed ID: 16424026
[TBL] [Abstract][Full Text] [Related]
5. Protein ISGylation and free ISG15 levels are increased by interferon gamma in breast cancer cells.
Tecalco-Cruz AC; Cruz-Ramos E
Biochem Biophys Res Commun; 2018 May; 499(4):973-978. PubMed ID: 29626479
[TBL] [Abstract][Full Text] [Related]
6. Evidence for an involvement of the ubiquitin-like modifier ISG15 in MHC class I antigen presentation.
Held T; Basler M; Knobeloch KP; Groettrup M
Eur J Immunol; 2021 Jan; 51(1):138-150. PubMed ID: 32686110
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.
Bektas N; Noetzel E; Veeck J; Press MF; Kristiansen G; Naami A; Hartmann A; Dimmler A; Beckmann MW; Knüchel R; Fasching PA; Dahl E
Breast Cancer Res; 2008; 10(4):R58. PubMed ID: 18627608
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis.
Fan JB; Arimoto K; Motamedchaboki K; Yan M; Wolf DA; Zhang DE
Sci Rep; 2015 Jul; 5():12704. PubMed ID: 26226047
[TBL] [Abstract][Full Text] [Related]
9. Interplay between interferon-stimulated gene 15/ISGylation and interferon gamma signaling in breast cancer cells.
Tecalco-Cruz AC; Cortés-González CC; Cruz-Ramos E; Ramírez Jarquín JO; Romero-Mandujano AK; Sosa-Garrocho M
Cell Signal; 2019 Feb; 54():91-101. PubMed ID: 30500379
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of ISG15 E3 ligase EFP through its autoISGylation.
Zou W; Wang J; Zhang DE
Biochem Biophys Res Commun; 2007 Mar; 354(1):321-7. PubMed ID: 17222803
[TBL] [Abstract][Full Text] [Related]
11. The Functional Roles of ISG15/ISGylation in Cancer.
Yuan Y; Qin H; Li H; Shi W; Bao L; Xu S; Yin J; Zheng L
Molecules; 2023 Jan; 28(3):. PubMed ID: 36771004
[TBL] [Abstract][Full Text] [Related]
12. Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon.
Yoo L; Yoon AR; Yun CO; Chung KC
Cell Death Dis; 2018 Jan; 9(2):97. PubMed ID: 29367604
[TBL] [Abstract][Full Text] [Related]
13. Regulation and action of interferon-stimulated gene 15 in breast cancer cells.
Tecalco-Cruz AC; Ramírez-Jarquín JO; Cruz-Ramos E
Hum Cell; 2020 Oct; 33(4):954-962. PubMed ID: 32813218
[TBL] [Abstract][Full Text] [Related]
14. ISG15 as a novel tumor biomarker for drug sensitivity.
Desai SD; Wood LM; Tsai YC; Hsieh TS; Marks JR; Scott GL; Giovanella BC; Liu LF
Mol Cancer Ther; 2008 Jun; 7(6):1430-9. PubMed ID: 18566215
[TBL] [Abstract][Full Text] [Related]
15. ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.
Zuo C; Sheng X; Ma M; Xia M; Ouyang L
Oncotarget; 2016 Nov; 7(45):74393-74409. PubMed ID: 27626310
[TBL] [Abstract][Full Text] [Related]
16. Non-muscle myosin IIA is post-translationally modified by interferon-stimulated gene 15 in breast cancer cells.
Cruz-Ramos E; Macías-Silva M; Sandoval-Hernández A; Tecalco-Cruz AC
Int J Biochem Cell Biol; 2019 Feb; 107():14-26. PubMed ID: 30529400
[TBL] [Abstract][Full Text] [Related]
17. A negative feedback of the HIF-1α pathway via interferon-stimulated gene 15 and ISGylation.
Yeh YH; Yang YC; Hsieh MY; Yeh YC; Li TK
Clin Cancer Res; 2013 Nov; 19(21):5927-39. PubMed ID: 24056783
[TBL] [Abstract][Full Text] [Related]
18. ISG15 in cancer: Beyond ubiquitin-like protein.
Han HG; Moon HW; Jeon YJ
Cancer Lett; 2018 Dec; 438():52-62. PubMed ID: 30213559
[TBL] [Abstract][Full Text] [Related]
19. Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.
Brown AR; Simmen RC; Raj VR; Van TT; MacLeod SL; Simmen FA
Carcinogenesis; 2015 Sep; 36(9):946-55. PubMed ID: 26210742
[TBL] [Abstract][Full Text] [Related]
20. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon.
Xu D; Zhang T; Xiao J; Zhu K; Wei R; Wu Z; Meng H; Li Y; Yuan J
Autophagy; 2015 Apr; 11(4):617-28. PubMed ID: 25906440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
